LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 85 of 166
Next
>>
>
2101 to 2125 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	CP466722	0.04	uM	LJP5	72	hr	1657	5939	5588	1.0631	1.0710
BT-20	CP466722	0.12	uM	LJP5	72	hr	1657	5575	5588	0.9979	0.9971
BT-20	CP466722	0.37	uM	LJP5	72	hr	1657	5847	5588	1.0463	1.0523
BT-20	CP466722	1.11	uM	LJP5	72	hr	1657	5755	5588	1.0298	1.0335
BT-20	CP466722	3.33	uM	LJP5	72	hr	1657	5382	5588	0.9630	0.9568
BT-20	CP466722	10	uM	LJP5	72	hr	1657	3529	5588	0.6316	0.5387
BT-20	CP724714	0.04	uM	LJP5	72	hr	1657	5207	5588	0.9319	0.9205
BT-20	CP724714	0.12	uM	LJP5	72	hr	1657	5078	5588	0.9088	0.8937
BT-20	CP724714	0.37	uM	LJP5	72	hr	1657	4890	5588	0.8751	0.8533
BT-20	CP724714	1.11	uM	LJP5	72	hr	1657	4568	5588	0.8175	0.7827
BT-20	CP724714	3.33	uM	LJP5	72	hr	1657	4497	5588	0.8051	0.7670
BT-20	CP724714	10	uM	LJP5	72	hr	1657	3680	5588	0.6587	0.5760
BT-20	Alvocidib	0.04	uM	LJP6	72	hr	1657	2798	5383	0.5198	0.3606
BT-20	Alvocidib	0.12	uM	LJP6	72	hr	1657	1396	5383	0.2596	-0.0960
BT-20	Alvocidib	0.37	uM	LJP6	72	hr	1657	1244	5383	0.2310	-0.1561
BT-20	Alvocidib	1.11	uM	LJP6	72	hr	1657	1130	5383	0.2096	-0.2035
BT-20	Alvocidib	3.33	uM	LJP6	72	hr	1657	1188	5383	0.2204	-0.1805
BT-20	Alvocidib	10	uM	LJP6	72	hr	1657	1169	5383	0.2165	-0.1898
BT-20	GW843682X	0.04	uM	LJP6	72	hr	1657	4886	5383	0.9077	0.8892
BT-20	GW843682X	0.12	uM	LJP6	72	hr	1657	3476	5383	0.6456	0.5456
BT-20	GW843682X	0.37	uM	LJP6	72	hr	1657	2170	5383	0.4027	0.1696
BT-20	GW843682X	1.11	uM	LJP6	72	hr	1657	1417	5383	0.2631	-0.0888
BT-20	GW843682X	3.33	uM	LJP6	72	hr	1657	1241	5383	0.2301	-0.1587
BT-20	GW843682X	10	uM	LJP6	72	hr	1657	1730	5383	0.3210	0.0238
BT-20	HG-5-113-01	0.04	uM	LJP5	72	hr	1657	5252	5588	0.9399	0.9300

|<
<<
Previous
Page 85 of 166
Next
>>
>
2101 to 2125 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)